Yonsa - (125 mg; Tablet, Oral)

Generic Name	Abiraterone acetate	Innovator	Sun Pharma
Dosage	125 mg; Tablet, Oral	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	None
Indication	Used to treat metastatic castration resistant prostate cancer.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
****	*** \ *********	***** *, ****	*******	********	*** ****** *******

Chronology Of Events